• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine

Drug Database Powered by:

  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Microbiome Times

Editor's Choice

The Selection of a Pre-Clinical Model is Driven by the Specific Research Question

May 13, 2025 Microbiome Times

At the Microbiome Times Partnering Forum, Massimo Marzorati, CEO of ProDigest, presents “The Selection of a Pre-Clinical Model is Driven by the Specific Research Question”. A talk highlighting the company’s expertise in simulating the gastrointestinal […]

Pharma & Human Health

A symbiotic gut fungus wards off liver disease in mice

May 7, 2025 Microbiome Times

Researchers have found a new ally in the fight against a serious liver disease: a symbiotic gut-dwelling fungus that produces a molecule shown to be capable of reversing disease progression in mice. The findings may […]

Pharma & Human Health

Study of facial bacteria could lead to probiotics that promote healthy skin

May 7, 2025 Microbiome Times

The composition of bacterial populations living on our faces plays a significant role in the development of acne and other skin conditions such as eczema. Two species of bacteria predominate in most people, but how […]

Pharma & Human Health

No more copy-pasting: DNA base editing for better Lactobacillus strains

April 29, 2025 Microbiome Times

A Kobe University team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms. This technique is indistinguishable from natural variation and enabled the researchers to create a strain that doesn’t […]

Finance

Microba Delivers Landmark IBD Results & Signs Major Gastro Partner

April 29, 2025 Microbiome Times

Microba Life Sciences Limited (ASX: MAP) (“Microba”) a precision microbiome company, announces two significant developments: the release of new clinical utility results for its MetaPanel™ gastrointestinal pathogen test, and the signing of a strategic clinical partnership […]

Pharma & Human Health

Scientists find gut-brain link that may affect behavior in children with autism

April 25, 2025 Microbiome Times

A new USC study suggests that gut imbalances in children with autism may create an imbalance of metabolites in the digestive system — ultimately disrupting neurotransmitter production and influencing behavioral symptoms. The research, published in […]

Pharma & Human Health

Some gut bacteria could make certain drugs less effective

April 16, 2025 Microbiome Times

A new study, published in Nature Chemistry by researchers from the University of Pittsburgh and Yale University, shows how common gut bacteria can metabolize certain oral medications that target cellular receptors called GPCRs, potentially rendering these important drugs less […]

Editor's Choice

Mental Health and the Brain-Gut-Microbiota Axis: Fundamental Importance of Diet

April 3, 2025 Microbiome Times

The Mediterranean diet is regarded as the most beneficial diet from a mental health perspective. The benefits of such a diet are mediated significantly through the brain- gut-microbiota axis. Abnormalities in this axis have been described in the most […]

Pharma & Human Health

New study sheds light on how bacteria ‘vaccinate’ themselves with genetic material from dormant viruses

March 27, 2025 Microbiome Times

Like people, bacteria get invaded by viruses. In bacteria, the viral invaders are called bacteriophages, derived from the Greek word for bacteria-eaters, or in shortened form, “phages.” Scientists have sought to learn how the single-cell […]

Editor's Choice

Novel In vitro Model Replicates Intestinal Microbiota Composition Without Requiring Anaerobic Incubation

March 25, 2025 Microbiome Times

The majority of the gut microbiota is unculturable using standard laboratory techniques, which has been well-documented since the advent of next generation sequencing in microbiome research. This limitation makes it difficult to characterise the phenotype […]

Finance

PepsiCo to Acquire fast-growing prebiotic soda brand for $1.95 billion

March 21, 2025 Microbiome Times

PepsiCo, Inc. (NASDAQ: PEP) (“PepsiCo”) announced on Monday that it has entered into a definitive agreement to acquire poppi, a fast-growing prebiotic soda brand, for $1.95 billion, including $300 million of anticipated cash tax benefits for a […]

Posts navigation

1 2 … 75 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • The Selection of a Pre-Clinical Model is Driven by the Specific Research Question
    May 13, 2025
  • Mental Health and the Brain-Gut-Microbiota Axis: Fundamental Importance of Diet
    April 3, 2025
  • Novel In vitro Model Replicates Intestinal Microbiota Composition Without Requiring Anaerobic Incubation
    March 25, 2025
  • Dynamic Microbiome Abundance Profiling: A new tool to solve challenges in microbiome analysis
    March 5, 2025
  • Scientists decode diet from stool DNA – no questions asked
    February 24, 2025
sign up

Sign up to the Microbiome Times newsletter